Biotech Analyst Harrison holds a virtual meeting with CEO Imran and CFO Sanford on April 30 hosted by BTIG.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RANI:
- Rani Therapeutics management to meet virtually with BTIG
- Rani Therapeutics price target lowered to $9 from $21 at Canaccord
- Rani Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
- Rani Therapeutics reports Q4 EPS (27c), consensus (31c)
- Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update